Sponsored
by Biovian
Gene Therapy: Can CDMOs Solve the Manufacturing Bottleneck?
The gene therapy market is booming. Viral vectors, the key delivery systems for gene therapies,…
07/06/2022 - 7 minutes
Oncolytic Virus
Covid-19 Vaccine Approvals Bring Hope and Challenges for Adenoviral Technology
The rise of adenoviral Covid-19 vaccines highlights the potential of companies using similar technology in…
25/03/2021 - 6 minutes
Oxford’s Covid-19 Vaccine Blazes Trail for Oncolytic Virus Firms
Since the debut of Imlygic in 2015, no other oncolytic virus cancer therapies have been…
26/01/2021 - 7 minutes
Enemy or Valuable Ally? How Biotech Uses Viruses for Good
Taking advantage of the ability of viruses to manipulate life is opening new doors for…
21/12/2020 - 7 minutes
This Startup is Making a Cancer Vaccine out of Viruses
Valo Therapeutics is operating both in the UK and Finland to develop a cancer vaccine…
27/03/2020 - 4 minutes
Transgene’s Cancer Vaccine Abandoned after Phase II Fail
French biotech Transgene has ceased the development of a therapeutic cancer vaccine that failed to…
13/12/2019 - 2 minutes
German Cancer Virotherapy Biotech Launches with €12M Series A
Abalos Therapeutics launches today with €12M in Series A funding to get the development of…
15/10/2019 - 2 minutes
Oncolytic Virus for Liver Cancer Ruled Futile in Phase III
A phase III trial testing an oncolytic virus treatment for liver cancer, developed by the…
02/08/2019 - 2 minutes
Boehringer Ingelheim Acquires Oncolytic Virus Biotech Company
Boehringer Ingelheim is paying €210M to acquire all the remaining shares of ViraTherapeutics, an Austrian…
13/09/2018 - 2 minutes
Researchers Take Aim at Pancreatic Cancer with a Modified Flu Virus
In an early study at Queen Mary University in London, a modified flu virus has…
25/01/2018 - 3 minutes
Meet John Beadle, the Serial Entrepreneur with the Key to Oncolytic Viruses
Serial entrepreneur John Beadle is now at the helm of PsiOxus, an Oxford biotech with…
26/10/2017 - 8 minutes
These Norwegian Biotech Execs are Bringing Back Cancer Vaccines & Oncolytic Viruses
We talked to CEO Øystein Soug and CMO Magnus Jäderberg of Targovax about why the…
03/07/2017 - 8 minutes
